Jefferies Group’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Jefferies Group’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-44,800	Closed	-$268K	–	2630
2013 Q4	$268K	Buy	+44,800	New	+$207K	﹤0.01%	1437

Jefferies Group's IDIX Position: Q1 2014 in Review

Jefferies Group sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q1 2014, closing a stake of 145,610 shares — an estimated $871K sold.

Jefferies Group first reported a position in IDIX in Q3 2013 and held it in 2 quarters. The position peaked at $1.15M in Q3 2013. 96 funds tracked by Wall St. Rank hold IDIX as of Q1 2014.

Jefferies Group reported no remaining IDENIX PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
Jefferies Group sold 145,610 IDENIX PHARMACEUTICALS INC shares in Q1 2014, an estimated $871K.
Jefferies Group first reported a position in IDENIX PHARMACEUTICALS INC in Q3 2013 and held it in 2 quarters.
Jefferies Group's IDENIX PHARMACEUTICALS INC position peaked at $1.15M in Q3 2013.
96 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q1 2014.

Based on Jefferies Group's 13F filing for Q1 2014, filed 16 May 2014.